# Latent Labs unveils Latent-X2, generating drug-like antibodies without optimisation rounds

Canonical page: https://technooptimist.io/stories/latent-labs-unveils-latent-x2-generating-drug-like-antibodies-without-483034f8
Date: 16 Dec 2025
About: [Latent Labs](https://technooptimist.io/companies/latent-labs.md) · [Latent-X2 & Latent-Y](https://technooptimist.io/ai/latent-x.md)
Original source: https://www.biopharmatrend.com/artificial-intelligence/latent-labs-unveils-ai-model-generating-antibodies-with-low-immunogenicity-and-drug-like-properties-1434/

Latent-X2 designs antibodies and peptides meant to be drug-ready on the first pass. On 18 hard targets, half yielded binders from just 4 to 24 designs each. Designs matched approved antibodies on manufacturability measures and caused little immune activation in human blood tests.

## Key facts

- Affinities from picomolar to nanomolar (company data).
- Low cytokine release in ten-donor T-cell assays.
- K-Ras peptides comparable to hits from trillion-scale screens, using far fewer sequences.
- Available to selected partners via API or browser.

---

The Techno Optimist tracks every frontier of technology, program by program: https://technooptimist.io/ (a Markdown version of any page: add .md to its URL; site map for agents: https://technooptimist.io/llms.txt).
Data API (JSON, realtime stream): https://technooptimist.io/developers. People read 5 pages free, then Reader $10/month; these Markdown pages are open to agents.